skip to content

Roche’s Full-Year Results 2021

Roche has published its Full Year results for 2021 prior to the opening of the Swiss Stock Exchange on Thursday, 3rd February 2022.

Agenda
OverviewSeverin Schwan, CEO Roche Group
Pharmaceuticals Division Bill Anderson, CEO Roche Pharmaceuticals
Diagnostics DivisionThomas Schinecker, CEO Roche Diagnostics
Financial Results Alan Hippe, Chief Financial and IT Officer
Questions and answers Bruno Eschli, Head of Investor Relations

Webinar Replay

Investors

Past IR Events
View more Events